Red Flags Detected

  • Securities Litigation (new) — Two shareholder class action lawsuits filed in 2024 alleging securities law violations regarding false statements about Tablo products and FDA processes.
NASDAQ: OM Outset Medical, Inc. 10-Q

Outset Medical revenue falls 6% as shareholder lawsuits allege securities fraud

Filed May 7, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 8, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade OM commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Feedback
View original filing on SEC.gov View full financials on EDGAR ↗

Generated by AI · Jun 2, 2026 1:07 AM